4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-021441
SVP, Head of Global Commercial acquired 10,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Porter Derrell SVP, Head of Global Commercial | 2019-03-26 | Grant or award | +10,000 | 31,688 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…